J&J Talc: $950M Punitive Damages Thrown Out

CEO & Founder at LlamaLab
LA Judge Sets Aside $950 Million in J&J Talc Punitive Damages: Compensatory Award Upheld
Los Angeles County Superior Court Judge Ruth Kwan vacated $950 million in punitive damages against Johnson & Johnson on March 13, granting judgment notwithstanding the verdict (JNOV) in the Mae Moore mesothelioma case. The court upheld the $16 million compensatory award and the jury's finding of causation. Both parties indicated plans to appeal.
The decision comes as J&J faces 67,115 pending cases in MDL-2738, the largest active MDL in federal court, following three dismissed bankruptcy attempts. A January 2026 special master recommendation in federal court supporting the admissibility of plaintiffs' general causation experts could advance initial federal ovarian cancer trials.
Punitive damages vacated due to insufficient proof of actual knowledge (Reuters)
Pending cases in MDL-2738 as of March 2026 (MDL Update)
Rejected J&J bankruptcy petitions to resolve talc claims (AP News)
Judicial Findings on Punitive Evidence
Judge Kwan's ruling evaluated whether evidence met the statutory standard for punitive damages under California law, which requires proving malice, oppression, or fraud by clear and convincing evidence: a higher evidentiary burden than the preponderance standard applicable to compensatory claims.
The court concluded the trial record did not satisfy that standard. "A review of the entire record read in context and even in a light most favorable to plaintiffs reveals little, if anything, to suggest that J&J actually knew asbestos existed in its products," Judge Kwan wrote.
The court also noted that "when J&J learned that asbestos might be present, it acted to address those findings," concluding that corporate testing and responses did not establish deliberate disregard under California law.
A review of the entire record read in context and even in a light most favorable to plaintiffs reveals little, if anything, to suggest that J&J actually knew asbestos existed in its products.
Judge Ruth KwanLos Angeles County Superior Court
The compensatory award and causation determination were maintained under the preponderance of the evidence standard. J&J litigation counsel stated the ruling properly addressed punitive standards, while plaintiffs' counsel indicated they will appeal the JNOV order.
Landscape Across State and Federal Courts
Talc litigation continues to produce divergent trial outcomes across jurisdictions:
In December 2025, a Baltimore jury awarded $1.56 billion in the Cherie Craft mesothelioma lawsuit (including $1.5 billion in punitive damages, currently pending appeal). That same month, a Minnesota jury returned a $65.5 million verdict in a lung cancer action, and a California jury awarded $40 million in an ovarian cancer case.
In February 2026, a Philadelphia jury found liability in an ovarian cancer trial with a $250,000 verdict.
Oct 2021
J&J creates subsidiary LTL Management and files Chapter 11; dismissed after finding debtor not in financial distress
Apr 2023
Second bankruptcy petition proposes $8.9 billion settlement over 25 years
2024-2025
Third bankruptcy petition through Red River Talc proposes $10 billion; dismissed in March 2025
Dec 2025
Baltimore jury awards $1.56 billion in Craft mesothelioma trial
Mar 2026
Judge Kwan vacates $950M punitive damages in Moore case while upholding compensatory award
Resolution of Bankruptcy Proceedings
Following the dismissal of its third bankruptcy petition in March 2025, J&J reversed its litigation reserve and returned to individual case litigation.
Federal Expert Admissibility Recommendations
In MDL-2738, retired Judge Freda Wolfson issued a 658-page special master report recommending that plaintiffs' epidemiology and toxicology experts be permitted to testify that cosmetic talc can cause ovarian cancer.
Adoption of the report by the presiding district judge will establish the scientific basis for scheduling initial federal ovarian cancer bellwether trials.
Implications for Law Firms
Evidentiary Standards for Damages
The Moore decision illustrates the distinct evidentiary requirements for compensatory versus punitive claims in cosmetic talc litigation:
- Compensatory damages require establishing product use, diagnosis confirmation (mesothelioma or ovarian cancer), and specific causation under the preponderance standard.
- Punitive damages require clear and convincing evidence demonstrating intentional corporate misconduct or actual knowledge of product contamination.
Medical Record Requirements
Building viable talc case files requires documentation across several clinical categories:
- Pathology reports establishing histologic subtype and tissue diagnosis
- Diagnostic imaging (CT, MRI, PET) and biopsy operative notes
- Longitudinal product exposure histories spanning decades of cosmetic use
- Occupational and residential histories ruling out alternative asbestos exposure sources
LlamaLab retrieves oncology, pathology, and hospital records in 4 days on average (with ~30-40% returned same-day on electronic requests) and uses insurance data to surface treatment locations clients don't always remember across multi-decade care histories. Invoices are itemized per case to flow through as recoverable case disbursements on settlement statements.
Next Steps
Key Points
Essential takeaways from this article
Summary
The Moore JNOV ruling reinforces the heightened evidentiary standard required for punitive awards in cosmetic talc claims, while leaving compensatory liability and causation intact.
Law firms handling talc inventories should ensure that case files contain complete pathology records, continuous medical histories, and substantiated product usage documentation.
Build Complete Talc Case Files
LlamaLab retrieves pathology reports, oncology records, and treatment histories in 4 days on average, using reverse provider search with insurance data to fill in treatment gaps.
Sources: Reuters, Legal Newsline/The Center Square, MDL Update, AP News, Reuters: Expert Testimony Ruling, Mesothelioma.net.
Stay Updated with Latest Insights
Get the latest articles about medical record retrieval and legal tech delivered to your inbox.




